406 related articles for article (PubMed ID: 22270037)
1. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
2. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
Danke NA; Yang J; Greenbaum C; Kwok WW
J Autoimmun; 2005 Dec; 25(4):303-11. PubMed ID: 16249070
[TBL] [Abstract][Full Text] [Related]
4. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
5. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
[TBL] [Abstract][Full Text] [Related]
6. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
[TBL] [Abstract][Full Text] [Related]
7. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
[TBL] [Abstract][Full Text] [Related]
8. A low antigen dose selectively promotes expansion of high-avidity autoreactive T cells with distinct phenotypic characteristics: a study of human autoreactive CD4+T cells specific for GAD65.
Oling V; Geubtner K; Ilonen J; Reijonen H
Autoimmunity; 2010 Dec; 43(8):573-82. PubMed ID: 20370569
[TBL] [Abstract][Full Text] [Related]
9. T cell responses to enterovirus antigens and to beta-cell autoantigens in unaffected children positive for IDDM-associated autoantibodies.
Juhela S; Hyöty H; Hinkkanen A; Elliott JF; Roivainen M; Kulmala P; Rahko J; Knip M; Ilonen J
J Autoimmun; 1999 Jun; 12(4):269-78. PubMed ID: 10330298
[TBL] [Abstract][Full Text] [Related]
10. High diversity in the TCR repertoire of GAD65 autoantigen-specific human CD4+ T cells.
Eugster A; Lindner A; Catani M; Heninger AK; Dahl A; Klemroth S; Kühn D; Dietz S; Bickle M; Ziegler AG; Bonifacio E
J Immunol; 2015 Mar; 194(6):2531-8. PubMed ID: 25681349
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
12. Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes.
Vadacca M; Valorani MG; von Hofe E; Kallinteris NL; Buzzetti R; Pozzilli P
Horm Metab Res; 2011 Jun; 43(7):483-8. PubMed ID: 21512962
[TBL] [Abstract][Full Text] [Related]
13. Circulating CD4+CD25 high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies.
Oling V; Marttila J; Knip M; Simell O; Ilonen J
Ann N Y Acad Sci; 2007 Jun; 1107():363-72. PubMed ID: 17804564
[TBL] [Abstract][Full Text] [Related]
14. Autoreactive T cells in human type 1 diabetes.
Tree TI; Peakman M
Endocrinol Metab Clin North Am; 2004 Mar; 33(1):113-33, ix-x. PubMed ID: 15053898
[No Abstract] [Full Text] [Related]
15. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes.
Boettler T; Pagni PP; Jaffe R; Cheng Y; Zerhouni P; von Herrath M
J Autoimmun; 2013 Aug; 44():40-8. PubMed ID: 23770292
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic dendritic cells induce antigen-specific hyporesponsiveness in insulin- and glutamic acid decarboxylase 65-autoreactive T lymphocytes from type 1 diabetic patients.
Segovia-Gamboa N; Rodríguez-Arellano ME; Rangel-Cruz R; Sánchez-Díaz M; Ramírez-Reyes JC; Faradji R; González-Domínguez É; Sánchez-Torres C
Clin Immunol; 2014 Sep; 154(1):72-83. PubMed ID: 24993292
[TBL] [Abstract][Full Text] [Related]
17. Autoreactive T cell response in CD25-negative fraction of peripheral blood mononuclear cells in established type 1 diabetes.
Moriyama H; Kotani R; Katsuta A; Kameno M; Arai T; Okumachi Y; Kishi M; Yamada K; Yasuda H; Hara K; Yokono K; Nagata M
Ann N Y Acad Sci; 2008 Dec; 1150():278-81. PubMed ID: 19120313
[TBL] [Abstract][Full Text] [Related]
18. The potential of multimer technologies in type 1 diabetes prediction strategies.
Fierabracci A
Diabetes Metab Res Rev; 2011 Mar; 27(3):216-29. PubMed ID: 21309048
[TBL] [Abstract][Full Text] [Related]
19. Emergence of a broad repertoire of GAD65-specific T-cells in type 1 diabetes patients with graft dysfunction after allogeneic islet transplantation.
Chujo D; Foucat E; Takita M; Itoh T; Sugimoto K; Shimoda M; Yagi K; Yamagishi M; Tamura Y; Yu L; Naziruddin B; Levy MF; Ueno H; Matsumoto S
Cell Transplant; 2012; 21(12):2783-95. PubMed ID: 22963904
[TBL] [Abstract][Full Text] [Related]
20. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
